Corey Davis, J.D., M.S.P.H., is deputy director of the Network’s Southeastern Region Office and the Director of the Harm Reduction Legal Project. Before joining NHeLP Corey served as Employment Rights Attorney at Equality Advocates Pennsylvania where he represented lesbian, gay, bisexual and transgender (LGBT) individuals before administrative commissions and in state and federal courts. Prior to joining Equality Advocates, Corey oversaw a street-based legal clinic sited at Philadelphia’s syringe exchange program. In both of these positions he provided direct legal representation as well as education, outreach and strategic advocacy.

Corey has also worked for the North Carolina Institute of Medicine, the University of Pennsylvania and the Drug Control and Access to Medicines Consortium in both research and management capacities. He is the recipient of the International AIDS Society’s Young Investigator Award, given for empirical research on the effect of law and law enforcement practice on access to an evidence-based public health intervention, and has published in the lay and academic press. Corey received his B.S. from the Indiana University of Pennsylvania, his M.S.P.H. from the University of North Carolina at Chapel Hill and his J.D. from Temple University. Corey is barred in Pennsylvania and New Jersey as well as various federal courts.
View a collection of research, resources and trainings produced by Corey below.

Articles & Resources

American Rescue Plan Act Provides Opportunity for Syringe Access

Law & Policy InsightsSubstance Use Prevention and Harm Reduction

March 30, 2021
by Corey Davis

President Biden signed the American Rescue Plan Act of 2021 (ARPA) into law on March 11, 2021. While most media attention focused on its headline provisions, including $1,400 stimulus checks for many individuals, $350 billion in aid to state, local, and tribal governments, and expansions in the Earned Income Tax Credit and child tax credit, the Act also contains historic assistance for harm reduction programs.

Read more

Ensuring Access to Clean Needles Can Save Lives, but Legal Barriers Persist

Law & Policy InsightsHarm Reduction Legal ProjectHarm Reduction Legal Project ResourcesOpioid Misuse and Overdose PreventionSubstance Use Prevention and Harm Reduction

February 5, 2021
by Amy Lieberman and Corey Davis

The United States continues to experience an unprecedented level of drug-related harm. While the failure to prevent this harm is most notable in the number of overdose deaths, which are now at their highest level on record, it is evident in other areas as well. Of particular importance from a policy perspective, bloodborne disease infections related to syringe sharing are also on the rise, with recent outbreaks in Kentucky, Massachusetts, and Indiana, among other states. Cases of infective endocarditis, which is caused largely by unsafe injection, are increasing as well.

Read more

Determining Whether Federal Law Prohibits the Mailing of Naloxone

Law & Policy InsightsHarm Reduction Legal ProjectHarm Reduction Legal Project ResourcesOpioid Misuse and Overdose PreventionSubstance Use Prevention and Harm Reduction

December 3, 2020
by Corey Davis

The Network’s Harm Reduction Legal Project works to address the legal and policy barriers that impede the establishment and expansion of evidence-based harm reduction measures such as naloxone distribution, syringe access programs, and access to evidence-based substance use disorder treatment. One of the questions frequently received by the Project is whether federal law prohibits harm reduction organizations and similar groups who are authorized to distribute naloxone from mailing the medication.

Read more

Naloxone Prescription Mandates

Fact SheetHarm Reduction Legal ProjectHarm Reduction Legal Project ResourcesOpioid Misuse and Overdose PreventionSubstance Use Prevention and Harm Reduction

October 22, 2020
by Amy Lieberman and Corey Davis

Drug overdose continues to claim the lives of tens of thousands of people in the U.S. every year. Opioids, both prescription painkillers and street drugs such as heroin and illicitly manufactured fentanyl, are responsible for the majority of these deaths. In response, states have passed legislation to increase access to the opioid overdose reversal medication naloxone, including provisions that allow for the distribution of naloxone through pharmacies. Some states have gone further and now require that naloxone be prescribed or offered to some patients. This fact sheet describes those requirements and links to the relevant laws.

View page

Q&A: Access to Care for Individuals with Opioid Use Disorder

Law & Policy InsightsCOVID-19Harm Reduction Legal ProjectHarm Reduction Legal Project ResourcesSubstance Use Prevention and Harm Reduction

October 6, 2020
by Amy Lieberman and Corey Davis

In this Q&A, Corey Davis, deputy director of the Network’s Southeastern Region Office and director of the Network’s Harm Reduction Legal Project; and Amy Lieberman, senior attorney, for the Network’s Harm Reduction Legal Project, discuss some of the key elements in the chapter they authored, Access to Care for Individuals with Opioid Use Disorder, for the Report.

Read more

Characteristics of Statewide Naloxone Distribution Mechanisms

50-state surveyOpioid Misuse and Overdose PreventionHarm Reduction Legal ProjectHarm Reduction Legal Project ResourcesSubstance Use Prevention and Harm Reduction

August 7, 2020
by Corey Davis

This fact sheet provides information on Pennsylvania's Act 139, which provides limited immunity to overdose victims and bystanders that seek medical help, and increases accesss to naloxone, a drug that can reverse the effects of an opioid overdose.

View page